Early Diagnosis in Glaucoma With GDxVcc
Launched by ARISTOTLE UNIVERSITY OF THESSALONIKI · Nov 30, 2009
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
To compare the Scanning Laser Polarimetry findings in subjects with exfoliation syndrome and normal controls and to evaluate the value of scanning laser polarimetry in the early diagnosis and management of exfoliative glaucoma. Prospective study in progress. The investigators compare and analyze the scanning laser polarimetry parameters in consecutive subjects with exfoliation syndrome and normal intraocular pressure and compared them with consecutive normal controls. Randomly selected patients with exfoliation syndrome and normal controls undergo a comprehensive ophthalmic exam which inclu...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Exfoliation material on pupil
- • Intraocular pressure below 21 mm Hg without therapy
- • No glaucomatous damage
- • Age between 60-75
- • Open angle
- Exclusion Criteria:
- • Other Ophthalmic diseases
- • Dry eye
- • Corneal disorders
- • Diabetic Retinopathy
- • Optic Neuropathy (other than glaucomatous neuropathy)
- • Ocular surgery or laser
About Aristotle University Of Thessaloniki
Aristotle University of Thessaloniki (AUTH) is a prestigious institution in Greece, renowned for its commitment to advancing knowledge and innovation in the field of clinical research. As a leading academic sponsor of clinical trials, AUTH leverages its extensive resources and expertise to conduct rigorous studies that contribute to the understanding of various medical conditions and the development of novel therapeutic interventions. The university fosters collaboration among multidisciplinary teams, ensuring adherence to the highest ethical standards and regulatory requirements while promoting scientific excellence and enhancing patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Thessaloniki, , Greece
Patients applied
Trial Officials
Antonios T Dimopoulos, MD
Study Director
1st University Department of Ophthalmogy
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials